{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:36:50Z","timestamp":1773160610462,"version":"3.50.1"},"reference-count":0,"publisher":"Managed Care and Healthcare Communications, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Manag Care"],"DOI":"10.37765\/ajmc.2023.89352","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T20:01:25Z","timestamp":1682539285000},"page":"e117-e123","source":"Crossref","is-referenced-by-count":4,"title":["Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists"],"prefix":"10.37765","volume":"29","member":"24492","published-online":{"date-parts":[[2023,4,20]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T20:01:27Z","timestamp":1682539287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/prior-authorization-requirements-for-calcitonin-gene-related-peptide-antagonists"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,1]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2023.89352","archive":["Portico","Portico"],"relation":{},"ISSN":["1936-2692","1088-0224"],"issn-type":[{"value":"1936-2692","type":"electronic"},{"value":"1088-0224","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,20]]}}}